Kappa Light-Chain Proximal Tubulopathy as a Reversible Renal Manifestation of Indolent Small Lymphocytic Lymphoma (KIDNEY WEEK 2026) - Oct 2, 2026 - Abstract #FR-PO0481; Pres time: Oct 23, 2026; 10:00 AM - 12:00 PM; Location: Exhibit Hall A, Convention Center; "Given renal involvement, splenomegaly, thrombocytopenia, and progressive lymphoma burden, treatment with obinutuzumab-based therapy, later combined with bendamustine, was initiated in August 2025. Kidney biopsy was essential in identifying LCPT and establishing renal involvement as an indication for therapy. Prompt clone-directed treatment resulted in hematologic response and complete renal recovery, emphasizing the importance of early recognition and tissue diagnosis in patients with lymphoproliferative disorders and unexplained kidney dysfunction."
Atherosclerosis • B Cell Lymphoma • Cardiovascular • Hematological Disorders • Hematological Malignancies • Lymphoma • Monoclonal Gammopathy • Nephrology • Non-Hodgkin's Lymphoma • Renal Disease • Small Lymphocytic Lymphoma • Thrombocytopenia
|
|
Ragibe Gulsah Dilaver; Sourabh Bidhan; Yihan Wang; Neil S. Sanghani
|